Comparison of the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intra-articular normal saline injection on pain, functional limitation, and range of motion in patients with knee osteoarthritis; a randomized controlled trial.

IF 2.2 3区 医学 Q2 ORTHOPEDICS
Alireza Teymouri, Nafiseh Birang, Maryamsadat Fakheri, Aref Nasiri
{"title":"Comparison of the efficacy of ultrasound-guided dextrose 25% hypertonic prolotherapy and intra-articular normal saline injection on pain, functional limitation, and range of motion in patients with knee osteoarthritis; a randomized controlled trial.","authors":"Alireza Teymouri, Nafiseh Birang, Maryamsadat Fakheri, Aref Nasiri","doi":"10.1186/s12891-025-08580-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Knee osteoarthritis (OA) is a debilitating condition that manifests as knee pain and dysfunction. Clinicians prefer non-surgical options such as intra-articular injections for mild to moderate disease. Dextrose prolotherapy (DPTx) has been shown to have a beneficial effect on knee OA in the long-term. In this randomized controlled trial (RCT), we aimed to compare DPTx with intra-articular normal saline injection (IA-NS) to treat knee OA in terms of effectiveness and patient-reported outcomes.</p><p><strong>Methods: </strong>The study was a double-blind RCT with an allocation ratio of 1:1. We used block randomization to assign patients to each treatment arm. Patients with a visual analog scale of at least 4 for pain, and a Kellgren-Lawrence scale of grade 2 or 3 (mild or moderate disease) were selected and assessed according to eligibility criteria. The participants received either 5 ml of 50% dextrose water or 5 ml of 0.9% sodium chloride. The patients were followed up at 2, 4, and 8 weeks. SPSS software was used for statistical analyses. All results were reported with a confidence interval of 95%, and a p-value of less than 0.05 was considered significant.</p><p><strong>Results: </strong>Overall, 55 patients were included in the study, but 50 completed the study process (25 patients in each treatment arm). The mean age of patients with knee OA was 62.98 ± 5.37, ranging from 55 to 74 years. We observed significant improvement in both groups in terms of knee pain, function, and knee extension degree at all follow-up visits (p < 0.001). Although DPTx was associated with better results than IA-NS, the difference was not statistically significant (p > 0.05). The adverse events were limited to injection-site pain and ecchymosis, which resolved by week 4.</p><p><strong>Conclusion: </strong>Although we achieved slightly better results with DPTx, this treatment technique was not clinically or statistically superior to IA-NS in terms of knee pain and function in the short-term. Therefore, both DPTx and IA-NS are effective and well tolerated treatment options for knee OA. However, more RCTs are needed to confirm these claims.</p>","PeriodicalId":9189,"journal":{"name":"BMC Musculoskeletal Disorders","volume":"26 1","pages":"313"},"PeriodicalIF":2.2000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11956196/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Musculoskeletal Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12891-025-08580-5","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Knee osteoarthritis (OA) is a debilitating condition that manifests as knee pain and dysfunction. Clinicians prefer non-surgical options such as intra-articular injections for mild to moderate disease. Dextrose prolotherapy (DPTx) has been shown to have a beneficial effect on knee OA in the long-term. In this randomized controlled trial (RCT), we aimed to compare DPTx with intra-articular normal saline injection (IA-NS) to treat knee OA in terms of effectiveness and patient-reported outcomes.

Methods: The study was a double-blind RCT with an allocation ratio of 1:1. We used block randomization to assign patients to each treatment arm. Patients with a visual analog scale of at least 4 for pain, and a Kellgren-Lawrence scale of grade 2 or 3 (mild or moderate disease) were selected and assessed according to eligibility criteria. The participants received either 5 ml of 50% dextrose water or 5 ml of 0.9% sodium chloride. The patients were followed up at 2, 4, and 8 weeks. SPSS software was used for statistical analyses. All results were reported with a confidence interval of 95%, and a p-value of less than 0.05 was considered significant.

Results: Overall, 55 patients were included in the study, but 50 completed the study process (25 patients in each treatment arm). The mean age of patients with knee OA was 62.98 ± 5.37, ranging from 55 to 74 years. We observed significant improvement in both groups in terms of knee pain, function, and knee extension degree at all follow-up visits (p < 0.001). Although DPTx was associated with better results than IA-NS, the difference was not statistically significant (p > 0.05). The adverse events were limited to injection-site pain and ecchymosis, which resolved by week 4.

Conclusion: Although we achieved slightly better results with DPTx, this treatment technique was not clinically or statistically superior to IA-NS in terms of knee pain and function in the short-term. Therefore, both DPTx and IA-NS are effective and well tolerated treatment options for knee OA. However, more RCTs are needed to confirm these claims.

超声引导下葡萄糖25%高渗前驱治疗与关节内生理盐水注射对膝关节骨性关节炎患者疼痛、功能受限及活动范围的影响比较一项随机对照试验。
背景和目的:膝关节骨关节炎(OA)是一种使人衰弱的疾病,表现为膝关节疼痛和功能障碍。临床医生更倾向于采用非手术疗法,如对轻度至中度疾病进行关节内注射。事实证明,葡萄糖增生疗法(DPTx)对膝关节 OA 有长期的疗效。在这项随机对照试验(RCT)中,我们旨在比较葡萄糖增生疗法与关节内生理盐水注射(IA-NS)治疗膝关节OA的有效性和患者报告结果:该研究为双盲 RCT,分配比例为 1:1。我们采用整群随机法将患者分配到每个治疗组。根据资格标准,我们选择了疼痛视觉模拟量表至少为 4 级、凯尔格伦-劳伦斯量表为 2 级或 3 级(轻度或中度疾病)的患者,并对其进行了评估。参与者接受 5 毫升 50%葡萄糖水或 5 毫升 0.9% 氯化钠。患者分别在 2 周、4 周和 8 周时接受随访。统计分析采用 SPSS 软件。所有结果的置信区间均为 95%,P 值小于 0.05 为显著:共有 55 名患者参与了研究,但有 50 人完成了研究过程(每个治疗组有 25 名患者)。膝关节 OA 患者的平均年龄为(62.98 ± 5.37)岁,从 55 岁到 74 岁不等。在所有随访中,我们观察到两组患者的膝关节疼痛、功能和膝关节伸展度均有明显改善(P 0.05)。不良反应仅限于注射部位疼痛和瘀斑,并在第 4 周时消失:结论:虽然我们使用 DPTx 取得了略微更好的效果,但就短期膝关节疼痛和功能而言,这种治疗技术在临床或统计学上都不优于 IA-NS。因此,DPTx 和 IA-NS 都是有效且耐受性良好的膝关节 OA 治疗方案。不过,还需要更多的研究性临床试验来证实这些说法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders 医学-风湿病学
CiteScore
3.80
自引率
8.70%
发文量
1017
审稿时长
3-6 weeks
期刊介绍: BMC Musculoskeletal Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of musculoskeletal disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The scope of the Journal covers research into rheumatic diseases where the primary focus relates specifically to a component(s) of the musculoskeletal system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信